Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What are the optimal strategies to communicate the risk of poor air quality exposure to vulnerable groups?

Frontiers in public health·2026
Same author

Bio-elimination of Chromium Using Bacillus Cereus Strains Isolated from Activated Sludge.

Current microbiology·2025
Same author

Development and characterisation of mgTHP-1, a novel <i>in vitro</i> model for neural macrophages with microglial characteristics.

Neurological research·2023
Same author

First Measurement of the Nuclear-Recoil Ionization Yield in Silicon at 100 eV.

Physical review letters·2023
Same author

Corrigendum to "Supplementing rabbit diets with butylated hydroxyanisole affects oxidative stress, growth performance, and meat quality" [Animal 15(9) (2021) 100339].

Animal : an international journal of animal bioscience·2023
Same author

Effect of different dietary fiber-rich extenders on the quality attributes of functional restructured buffalo meat fillets.

Iranian journal of veterinary research·2023

Related Experiment Video

Updated: Jul 15, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Giant cell arteritis: recent advances and guidelines for management.

B Dasgupta1, N Hassan,

  • 1Essex University, and Department of Rheumatology, Southend University Hospital, Prittlewell Chase, Westcliff-on-Sea, Essex, UK. Bhaskar.Dasgupta@southend.nhs.uk

Clinical and Experimental Rheumatology
|April 13, 2007
PubMed
Summary

Giant cell arteritis (GCA) diagnosis and management are reviewed, focusing on temporal artery biopsy histology and advanced imaging like ultrasound and PET scans. This provides insights for updated clinical practice guidelines.

Related Experiment Videos

Last Updated: Jul 15, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Area of Science:

  • Rheumatology
  • Pathology
  • Radiology

Background:

  • Giant cell arteritis (GCA) is a significant vasculitis affecting large arteries.
  • Accurate diagnosis and staging are crucial for effective management.
  • Histopathological findings in temporal artery biopsy (TAB) and imaging modalities play key roles.

Purpose of the Study:

  • To review recent advancements in the epidemiology and pathology of GCA.
  • To evaluate the diagnostic and prognostic value of TAB histology.
  • To assess the utility of novel imaging techniques and propose management guidelines.

Main Methods:

  • Review of current literature on GCA epidemiology, pathology, and diagnostics.
  • Analysis of immuno-histochemical findings in TAB specimens.
  • Evaluation of duplex ultrasonography and FDG-PET scanning in disease staging.
  • Synthesis of treatment evidence to inform management strategies.

Main Results:

  • TAB histology offers diagnostic and prognostic information.
  • Advanced imaging techniques like duplex ultrasonography and FDG-PET scanning aid in diagnosis and staging disease extent.
  • Evidence synthesis supports the development of management guidelines.

Conclusions:

  • Integrated diagnostic approaches combining TAB and advanced imaging improve GCA assessment.
  • Updated management guidelines are needed based on current evidence for optimal patient outcomes.
  • Further research into GCA pathogenesis and treatment is warranted.